From March 13, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on March 16, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.39 CNY | +1.79% | -1.16% | -40.76% |
1st Jan change | Capi. | |
---|---|---|
-40.76% | 83Cr | |
+40.73% | 73TCr | |
+32.83% | 59TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 20TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- 301246 Stock
- News Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
- Tranche Update on Hubei Hongyuan Pharmaceutical Technology Co., Ltd.'s Equity Buyback Plan announced on March 16, 2024.